Delivery Order SPE2DB24D2205-SPE2DB24FDVXH

Award Date 6/21/24
Potential Completion Date 7/15/24
Potential Value $8.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML. The firm-fixed-price contract has a ceiling value of $12,330.68 and an ultimate completion date of February 20, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $3,082.67 for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance through February 3, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $6,165.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BENLYSTA 200 MG/ML AUTOINJEC ML, a pharmaceutical product. The contract has a period of performance through February 13, 2025 and is structured as a firm fixed-price delivery order. This award does not have a set-aside designation, indicating open competition....
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML. The contract has a ceiling value of $6,165.34 and a completion date of January 24, 2025. It is a Firm Fixed Price Delivery Order contract type. The contract is not designated under any set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $6,165.34 and is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of February 13, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant...
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $5,586.06, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 13, 2024. The contract is not designated as a set-aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BENLYSTA 200 MG/ML AUTOINJECTML. The $5,779.12 firm fixed-price delivery order contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,779.12 firm fixed-price delivery order is for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty medication. The contract has an ultimate completion date of December 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML. The firm-fixed-price, $5,779.12 delivery order has a completion date of December 27, 2024 and does not have a set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTOR medication to the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The $16,758.18 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp., a major pharmaceutical distributor, on October 8, 2024. The contract has an ultimate completion date of October 30, 2024 and is not set aside for any special business category. Amerisourcebergen has a significant Indefinite Delivery...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDVXH
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML. The award, valued at $8,379.09, is a Firm Fixed Price Delivery Order contract with a completion date of July 15, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis.

Generated 9/20/24, 9:18 AM